RecruitingPhase 1Phase 2NCT06410001
CE-STAND: Cervical Epidural STimulation After Neurologic Damage
Sponsor
University of Minnesota
Enrollment
36 participants
Start Date
Mar 15, 2026
Study Type
INTERVENTIONAL
Conditions
Summary
CE-STAND aims to address three areas under-represented in research: chronic, cervical, and autonomic dysfunction. It is both significant and highly impactful, as treating autonomic dysfunction could substantially improve function and quality of life (QoL) in chronic cervical SCI patients.
Eligibility
Min Age: 22 Years
Inclusion Criteria10
- Twenty two years of age or older
- Able to undergo the informed consent/assent process
- Stable, motor-complete SCI
- Discrete SCI between C4 and C7 (upper extremity weakness)
- ASIA A or B SCI Classification
- Medically stable in the judgment of the PI
- Intact segmental reflexes below the lesion of injury
- Greater than 1 year since initial injury and at least 6 months from any required spinal instrumentation
- Normal or corrected-to-normal vision to accurately perceive visual stimuli on the N-back task screen, and sufficient hearing ability to accurately perceive auditory stimuli during the task
- Willing to attend all scheduled appointments
Exclusion Criteria17
- Diseases and conditions that would increase the morbidity and mortality of this surgery such as cardiopulmonary.
- Individuals who require respiratory support, including ongoing or intermittent use of a ventilator and/or diaphragmatic pacer
- Inability to withhold antiplatelet/anticoagulation agents perioperatively
- Individuals who have history of recurrent autonomic dysreflexia in the judgment of the PI
- Significant dysautonomia that would prohibit rehabilitation or any history of cerebrovascular accident or myocardial infarction associated with autonomic dysreflexia. A single tilt table test with syncope, presyncope, or SBP \< 50 or \> 200
- Failure to exhibit cardiovascular autonomic dysfunction on tilt table testing
- Other conditions that would make the subject unable to participate in testing/rehabilitation in the judgment of the PI
- Patients who have participated in another study within the last 12 months in which they have received fluoroscopic or other related radiation exposure
- Current and anticipated need for opioid pain medications or pain that would prevent full participation in the program in the judgment of the PI
- Clinically significant mental illness in the judgment of the PI
- Treatment with botulinum toxin, intrathecal baclofen pump, and antispasmodics will not be permitted unless discussed with and approved by the study PI
- Patients with a history of significant depression or drug abuse
- Volitional movements present during EMG testing in bilateral lower extremities
- Unhealed spinal fracture
- Presence of significant contracture with loss of greater than two-thirds range of motion
- Presence of pressure ulcers
- Current Pregnancy
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICEEpidural Spinal Cord Stimulation System
Abbott Eterna system implantable pulse generator (IPG), charger, and TriCentrus lead
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06410001
Related Trials
Shockwave for Elbow and Wrist Spasticity in People With Spinal Cord Injury
NCT075014291 location
MEP Up-conditioning to Target Corticospinal Plasticity
NCT069899051 location
Safety and Feasibility of Intranasal Insulin in Patients With Spinal Cord Injury
NCT073840521 location
Upper Limb Nerve Cryoneurolysis is Non Inferior to the Usual Care and Has Therapeutic Add Value in Dealing With Shoulder Pain and Functional Problems Caused by Spasticity and Motor Impairment
NCT067824641 location
The Effect of Targeting the Plantaris Muscle-tendon in Surgical Correction of Ankle Equinus in Children
NCT070900571 location